Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial
The objectives of this study are to determine the efficacy of tamsulosin compared to placebo in reducing post-operative urinary retention and improving other clinical outcomes in people undergoing pulmonary surgery.
- EligibilityCriteria: Inclusion Criteria ( 2 or more of the following risk factors):  Male Sex Age greater than or equal to 40 years History of Diabetes Mellitus Prior pelvic irradiation Use of indwelling Thoracic Epidural analgesia Prior history of urinary retention  AND  International Prostate Specific Score greater than or equal to 1.  Exclusion Criteria:  Active treatment of Benign Prostatic Hyperplasia (BPH) Hypersensitivity or allergy to tamsulosin HCL Active treatment with tamsulosin or other alpha-blocker or uses of tamsulosin/ other alpha-blocker within 3 weeks of enrollment date Active urinary tract infection History of urological disorder specified as urethral stricture, BPH, bladder or prostate malignancy. History of urological surgery (Transurethral resection of the Prostate, Transurethral resection of the Bladder, Bladder suspension, prostatectomy) Underlying neurological disorders resulting in impaired bladder function Any known contraindication to the use of tamsulosin HCL - HealthyVolunteers: No - Gender: All - MinimumAge: 40 Years - StdAgeList: Adult, Older Adult